IGF-1 Gene Transfer to Human Synovial MSCs Promotes Their Chondrogenic Differentiation Potential without Induction of the Hypertrophic Phenotype

<div>The results of histology and immunostaining assessments. (a) S-O; safranin-O (upper lane), T-B; toluidine blue (lower lane). Control (left) versus IGF-1 gene transferred cell-derived pellets (right). Scale bars = 500 <i>μ</i>m. (b) S-O; safranin-O (upper lane), Col2; type II collagen (middle), and Col10; type X collagen (lower) immunostaining. Control (left) versus IGF-1 gene transfer (right). Scale bars = 200 <i>μ</i>m.</div>

Stem Cells International

fig3

Figure 3

Figure 3: IGF-1 Gene Transfer to Human Synovial MSCs Promotes Their Chondrogenic Differentiation Potential without Induction of the Hypertrophic Phenotype 

Figure 3 | IGF-1 Gene Transfer to Human Synovial MSCs Promotes Their Chondrogenic Differentiation Potential without Induction of the Hypertrophic Phenotype 